Research Paper Volume 13, Issue 9 pp 12896—12918

Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients

The glycolysis-related risk signature could predict survival rate and metastasis of OS patients. (A) Kaplan-Meier survival curve of overall survival rate among OS patients from the low-risk group and the high-risk group. Patients in high-risk group had the poorer prognosis. (B) Survival prediction between risk score and single gene was assessed by time-dependent receiver operating characteristic (ROC) curve for 1 years. (C) Survival prediction between risk score and single gene was assessed by time-dependent receiver operating characteristic (ROC) curve for 3 years. (D) Risk scores among metastasis and non-metastasis groups. (E, F) Kaplan-Meier survival curve of overall survival rate for prognostic value of risk signature for the patients divided by clinical feature of metastasis.

Figure 3. The glycolysis-related risk signature could predict survival rate and metastasis of OS patients. (A) Kaplan-Meier survival curve of overall survival rate among OS patients from the low-risk group and the high-risk group. Patients in high-risk group had the poorer prognosis. (B) Survival prediction between risk score and single gene was assessed by time-dependent receiver operating characteristic (ROC) curve for 1 years. (C) Survival prediction between risk score and single gene was assessed by time-dependent receiver operating characteristic (ROC) curve for 3 years. (D) Risk scores among metastasis and non-metastasis groups. (E, F) Kaplan-Meier survival curve of overall survival rate for prognostic value of risk signature for the patients divided by clinical feature of metastasis.